Pediatric Subjects With Tinea Corporis
- Registration Number
- NCT02227290
- Lead Sponsor
- Merz North America, Inc.
- Brief Summary
The study is being done to see how well the study cream works when applied once a day to affected area of child (where they have ringworm). The results will be compared to those seen with a placebo cream which has no active ingredient. Safety of the cream will also be measured.
- Detailed Description
The objectives of this study are to evaluate the safety and efficacy of Naftin (naftifine hydrochloride) Cream, 2% applied once daily for 2 weeks, compared to its vehicle in the treatment of pediatric subjects aged 2 to 17 years and 11 months with positive potassium hydroxide (KOH), positive dermatophyte culture, and clinical signs and symptoms of tinea corporis.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 230
- Males or non-pregnant females 2 years of age to 17 years, 11 months, of any race. Females of child bearing potential must have a negative urine pregnancy test.
- Presence of tinea corporis by clinical evidence of a tinea infection of at least moderate erythema, moderate induration, and mild pruritus.
- KOH positive and culture positive baseline skin scrapings obtained form the site with the mose severely affected lesion or a representative site of the overall severity.
- Tinea infection of the face, scalp, groin, and/or feet
- A life-threatening condition in the opinion of the investigator (ex. autoimmune deficiency syndrome, cancer, etc) within the last 6 months.
- Subjects with abnormal findings- physical or laboratory- that are considered by the investigator to be clinically important and indicative of conditions that might complicate interpretation of study results
- Subjects with a known hypersensitivity or other contradictions to study medications or their components.
- Subjects who have a recent history or who are currently known to abuse alcohol or drugs.
- Uncontrolled diabetes mellitus.
- Hemodialysis or chronic ambulatory peritoneal dialysis therapy.
- Current diagnosis of immunocompromising conditions.
- Current evidence of compromised skin, atopic or contact dermatitis, eczema, impetigo, lichen planus, pityriasis rosea, pityriasis versicolor, psoriasis, seborrhoeic dermatitis and syphilis.
- Severe dermatophytoses, mucocutaneous candidiasis, or bacterial skin infection
- Patients with tinea corporis who have concurrent dermatophytosis of the scalp, beard or nails.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Naftin Cream, 2% Naftin Cream Once Daily Placebo Cream Placebo Cream Once Daily
- Primary Outcome Measures
Name Time Method Primary Efficacy Day 21 Complete cure defined by negative KOH result and negative dermatophyte culture
- Secondary Outcome Measures
Name Time Method Secondary Efficacy Day 21 Treatment Effectiveness defined as negative KOH, negative culture, and improved sign and symptoms.
Trial Locations
- Locations (19)
Merz Investigative Site#507001
π΅π¦Panama City, Panama
Merz Investigative Site#001279
π΅π·Cidra, Puerto Rico
Merz Investigative Site#001097
πΊπΈNashville, Tennessee, United States
Merz Investigative Site#001316
πΊπΈTucson, Arizona, United States
Merz Investigative Site#001312
πΊπΈMiami, Florida, United States
Merz Investigative Site#180002
π©π΄San Cristobal, Dominican Republic
Merz Investigative Site# 180001
π©π΄Santo Domingo, Dominican Republic
Merz Investigative Site#001314
πΊπΈHenderson, Nevada, United States
Merz Investigative Site#001311
πΊπΈMiami, Florida, United States
Merz Investigative Site #001310
πΊπΈMiramar, Florida, United States
Merz Investigative Site#001313
πΊπΈFremont, California, United States
Investigative Site# 0010320
πΊπΈEncino, California, United States
Merz Investigative Site#001301
πΊπΈSan Diego, California, United States
Merz Investigative Site#001309
πΊπΈOmaha, Nebraska, United States
Merz Investigative Site#001307
πΊπΈSaint Joseph, Missouri, United States
Merz Investigative Site#001126
πΊπΈRaleigh, North Carolina, United States
Investigative Site# 0010319
πΊπΈGresham, Oregon, United States
Merz Investigative Site#001293
πΊπΈWinston Salem, North Carolina, United States
Merz Investigative Site#504001
ππ³San Pedro Sula, Honduras